188 related articles for article (PubMed ID: 25394244)
1. Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat.
Rocha J; Figueira ME; Barateiro A; Fernandes A; Brites D; Pinto R; Freitas M; Fernandes E; Mota-Filipe H; Sepodes B
Shock; 2015 Apr; 43(4):369-78. PubMed ID: 25394244
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R
Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734
[TBL] [Abstract][Full Text] [Related]
3. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.
Collino M; Aragno M; Castiglia S; Tomasinelli C; Thiemermann C; Boccuzzi G; Fantozzi R
Diabetes; 2009 Jan; 58(1):235-42. PubMed ID: 18840784
[TBL] [Abstract][Full Text] [Related]
4. Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.
Dugo L; Collin M; Allen DA; Murch O; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2006 May; 34(5):1489-96. PubMed ID: 16557150
[TBL] [Abstract][Full Text] [Related]
5. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala EM; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2005 Sep; 33(9):1903-12. PubMed ID: 16148458
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3β prevents activation of focal adhesion kinase after ischemia/reperfusion of the rat lung.
Waldow T; Witt W; Matschke K
Clin Hemorheol Microcirc; 2010; 46(2-3):169-81. PubMed ID: 21135492
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting glycogen synthase kinase 3beta in sepsis.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation.
Dugo L; Abdelrahman M; Murch O; Mazzon E; Cuzzocrea S; Thiemermann C
Shock; 2006 May; 25(5):485-91. PubMed ID: 16680013
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase (GSK)-3-β improves liver microcirculation and hepatocellular function after hemorrhagic shock.
Jellestad L; Fink T; Pradarutti S; Kubulus D; Wolf B; Bauer I; Thiemermann C; Rensing H
Eur J Pharmacol; 2014 Feb; 724():175-84. PubMed ID: 24389157
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β.
Liu H; Ou S; Xiao X; Zhu Y; Zhou S
Am J Med Sci; 2015 Sep; 350(3):204-11. PubMed ID: 26226547
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
13. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice.
Bao Z; Lim S; Liao W; Lin Y; Thiemermann C; Leung BP; Wong WS
Am J Respir Crit Care Med; 2007 Sep; 176(5):431-8. PubMed ID: 17556716
[TBL] [Abstract][Full Text] [Related]
15. The Akt/GSK-3β pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats.
Sun B; Chen L; Wei X; Xiang Y; Liu X; Zhang X
Biochem Biophys Res Commun; 2011 Jun; 409(4):808-13. PubMed ID: 21624354
[TBL] [Abstract][Full Text] [Related]
16. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta.
Whittle BJ; Varga C; Pósa A; Molnár A; Collin M; Thiemermann C
Br J Pharmacol; 2006 Mar; 147(5):575-82. PubMed ID: 16314851
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
18. GSK-3β Inhibitor Induces Expression of the TLR4/MyD88/NF-κB Signaling Pathway to Protect Against Renal Ischemia-Reperfusion Injury During Rat Kidney Transplantation.
Su S; Zhang P; Zhang Q; Yin Z
Inflammation; 2019 Dec; 42(6):2105-2118. PubMed ID: 31440938
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice.
Huang S; Wang H; Turlova E; Abussaud A; Ji X; Britto LR; Miller SP; Martinez A; Sun HS; Feng ZP
CNS Neurosci Ther; 2017 May; 23(5):405-415. PubMed ID: 28256059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
